Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-04-09
2000-02-29
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514258, 544117, 544279, C07D47104, A61K 31505
Patent
active
060309695
ABSTRACT:
A compound having the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are defined, a method for inhibiting adenosine kinase by administering a compound thereof, a pharmaceutical composition comprising a therapeutically effective amount of a compound thereof above in combination with a pharmaceutically acceptable carrier, a method of treating cerebral ischemia, epilepsy, pain, nociperception, inflammation and sepsis in a mammal in need of such treatment, comprising administering to the mammal a therapeutically effective amount of a compound thereof, and methods for preparation thereof.
REFERENCES:
patent: 5026851 (1991-06-01), Taylor et al.
patent: 5034393 (1991-07-01), Hackler et al.
patent: 5736547 (1998-04-01), Gangjee
patent: 5821244 (1998-10-01), Schaper et al.
Bennett, L. L., et al., "Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine", Mol. Pharmacol., 2:432-443 (1966).
Burnstock, G., "A Basis for Distinguishing Two Types of Purinergic Receptor", Cell Membrane Receptors for Drugs and Hormones, Raven Press, NY (1978).
Caldwell, I. C., et al., "Resistance to Purine Ribonucleoside Analogues in an Ascites Tumor", Canadian Journ. Of Biochemistry, 45:735-744 (1967).
Corradetti, R., et al., "Adenosine Decreases Aspartate and Glutamate Release from Rat Hippocampal Slices", European Journ. Of Pharm., 104:19-26 (1984).
Cronstein, B. N., "Adenosine, an endogenous anti-inflammatory agent", Journ. Of Applied Physiology, 76:5-13 (1994).
Davies, L. P., et al., "Halogenated Pyrrolopyrimidine Analogues of Adenosine from Marien Organisms: Pharmacological Activities and Potent Inhibition of Adenosine Kinase", Biochemical Pharmacology, 33(3):347-355 (1984).
Dragunow, M., "Adenosine: the brain's natural anticonvulsant?", Trends in Pharmacological Sciences, 7:128-130 (1986).
Firestein, G.S., et al., Selectin-Mediated Anti-inflammatory Effects of Adenosine (ADO) And an ADO Kinase Inhibitor, Arthritis and Rheumatism, 36:48s (1993).
Fredholm, B. B., et al., "VI. Nomenclature and Classification of Purinoceptors", Pharmacological Reviews, 46(2):143-156 (1994).
Gupta, A., et al., "Fluorine containing Biologically Active Agents: Synthesis of some New Pyrimidine Derivatives", J. Indian Chem. Soc., 71:635-636 (1994).
Hagen, V., et al., "Potentielle Kardiotonika", Pharmazie, 46:531-532 (1991).
Hershfield & Kredich, "Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosyl-homocysteine hydrolase inactivation, and dATP accumulation", Proc. Natl. Acad. Sci. USA, 77(7):4292-4296 (1980).
Hurlbert, B. S., et al., "Studies on Condensed Pyrimidine Systems, XXV, 2,4-Diaminopyrido[2,3-d]pyrimidines. Biological Data", Journ. Of Medicinal Chemistry, 11:711-717 (1968).
Kredich & Hershfield, "Immunodeficiency Diseases Caused by Adenosine Deaminase Deficiency and Purine Nucleoside Phosphorylase Deficiency", The Metabolic Basis of Inherited Disease, 6.sup.th ed., McGraw Hill, NY, pp. 1045-1075 (1989).
Londos, C., et al., "Subclasses of external adenosine receptors", Proc. Natl. Acad. Sci. USA, 77(5):2551-2554 (1980).
Miller & Hsu, "Adenosine Receptors: Mechanisms of Action and Physiological Role in CNS", Journal of Neurotrauma, 9:563S-577S (1992).
Miller, et al., "Adenosine Kinase from Rabbit Liver", The Journ. Of Biol. Chem., 254(7):2339-2345, (1979).
Moser, G. H., et al., "Turnover of adenosine in plasma off human and dog blood", Amer. Journ. Of Physiology, 25:C799-C806 (1989).
Mullane & Williams, "Adenosine and Cardiovascular Function", Adenosine and Adenosine Receptors, Humana Press, NJ, pp. 289-334 (1990).
Prakash, L., et al., "Novel condensation products of 2-amino-3-cyano-4,6-disubstituted pyridine with urea, thiourea, formanide and carbon disulfide", Pharmazie, 48:221-222 (1993).
Robins, R. K., et al., "Studies on Condensed Pyrimidine Systems. XIX. A New Synthesis of Pyrido [2,3-d]pyrimidines. The Condensation of 1,3-Diketones and 3-Ketoaldehydes with 4-Aminopyrimidines", 80:3449-3457 (1958).
Rudolphi, K. A., et al., "Adenosine and Brain Ischemia", Cerebrovascular and Brain Metabolism Reviews, 4:346-369 (1992).
Rudolphi, K. A., et al., "Neuroprotective role of adenosine in cerebral ischaemia", Trends in Pharmacological Sciences, 13:439-445 (1992).
Sawynok, J., et al., "Classification of adenosine receptors mediating antinociception in the rat spinal cord", Br. J. Pharmac., 88:923-930 (1986).
Sharma, R., et al., "Synthesis of 5,7-disubstituted pyridol[2,3-d]-pyrimidine derivatives and their antibacterial activity", Indian Journ. Of Chem., 31(B):719-720 (1992).
Suttle, D. P., et al., "Pyrazofurin-Resistant Hepatoma Cells Deficient in Adenosine Kinase", Europ. J. Cancer, 17:43-51 (1981).
Sweeney, M. I., et al., "Involvement of Adenosine in the Spinal Antinociceptive Effects of Morphine and Noradrenaline.sup.1 ", The Journ. Of Pharm. And Exp. Therapeutics, 243(2):657-665 (1987).
Victory, P., et al., "Two Step Synthesis of Pyrido[2,3-d]pyrimidines from Acyclic Precursors. Cyclization of 2-Cyanamino-4,6-diphenylpyridine-3-carbonitrile by Hydrogen Halides", Tetrahedron, 51(37):10253-10258 (1995).
Williams, M., "Purinoceptors in Central Nervous System Function", Psychopharmacology: the Fourth Gen. Of Prog., 643-655 (1995).
Wotring and Townsend, "Study of the Cytotoxicity and Metabolism of 4-Amino-3-carboxamido-1-(.beta.-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine Using Inhibitors of Adenosine Kinase and Adenosine Deaminase.sup.1 ", Cancer Research, 39:3018-3023 (1979).
Bhagwat Shripad S.
Gu Yu-Gui
Perner Richard J.
Abbott Laboratories
Miller Robert A.
Rao Deepak R.
Shah Mukund J.
LandOfFree
5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5,6,7-trisubstituted-4-aminopyrido[2,3-D] pyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683234